Scientists have discovered a new mechanism that acts via an immune cell and points toward a different way of treating chronic ...

Kaplan–Meier curves showed that extended adjuvant pyrotinib administered after trastuzumab-based adjuvant therapy provides a promising survival benefit in patients with high-risk HER2-positive breast ...